Annotation Detail

Information
Associated Genes
CBL
Associated Variants
CBL MUTATION
CBL MUTATION
Associated Disease
pancreatic ductal adenocarcinoma
Source Database
DisGeNET
Description
These results suggest that dysregulation of ubiquitination is a key mechanism of EGFR hyperactivation in PDAC and that low CBL may define PDAC tumors likely to respond to erlotinib treatment.
Pubmed
25348515
Section of the abstract supporting the evidence
CONCLUSIONS
Number of the section of the abstract supporting the evidence
4
Number of the sentence supporting the evidence
14
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000271441872080303
Drugs